Medios AG Logo

Medios AG

Wholesale and manufacturing of specialty pharmaceuticals for complex and rare diseases.

ILM1 | F

Overview

Corporate Details

ISIN(s):
DE000A1MMCC8 (+1 more)
LEI:
391200Z7Z09IHDBT2L23
Country:
Germany
Address:
Heidestraße 9, 10557 Berlin

Description

Medios AG is a specialty pharmaceutical company focused on providing solutions for complex and rare diseases. The company's core business encompasses two main segments: the wholesale distribution of specialty pharma drugs and the manufacturing of patient-specific therapies. The manufacturing division compounds personalized medications, such as sterile infusions, for individual patients. As a comprehensive partner, Medios covers critical aspects of the supply chain for specialized pharmacies, medical practitioners, and pharmaceutical companies. The company is also dedicated to advancing individualized medicine by pioneering biotechnological precision medicine and advanced therapies to provide patients with innovative treatments.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-14 07:50
Medios starts 2025 financial year successfully with significant increase in ear…
English 20.7 KB
2025-05-13 00:00
Q1 statement / Q1 financial report 2025
English 10.1 MB
2025-05-12 18:58
Medios repositions itself for the next phase of its corporate development
English 12.7 KB
2025-04-14 15:06
Medios AG: Bekanntmachung der Einberufung zur Hauptversammlung am 27.05.2025 in…
German 256.2 KB
2025-03-25 07:50
Medios expects further growth in revenue and earnings after record year 2024
English 20.3 KB
2025-03-25 00:00
Annual financial report 2024
English 4.1 MB
2025-03-05 08:50
Preliminary figures for Medios AG 2024: Significant increase in earnings and ma…
English 12.3 KB
2025-03-04 08:50
Preliminary figures for Medios AG 2024: Significant increase in earnings and ma…
English 12.3 KB
2025-02-28 16:07 English 3.8 KB
2025-02-27 15:58 English 3.9 KB
2025-01-04 12:50 English 14.1 KB
2025-01-03 12:50 English 14.1 KB
2024-12-24 15:00 English 15.5 KB
2024-12-23 15:00 English 15.5 KB
2024-12-13 13:27
Medios AG: Specification of the full-year forecast
English 9.3 KB

Automate Your Workflow. Get a real-time feed of all Medios AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medios AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Medios AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-08-19 van Rietschoten, Constantijn Board Buy None 162,805.82 EUR
2023-06-28 Prußeit, Christoph Board Buy None 39,100.00 EUR
2021-12-09 Miehler, Mi-Young Board Other None 3,550,000.00 EUR
2021-12-09 Prußeit, Christoph Board Other None 1,775,000.00 EUR
2021-12-09 Miehler, Mi-Young Board Other None 700,000.00 EUR
2021-12-09 Prußeit, Christoph Board Other None 350,000.00 EUR

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.